CINCINNATI, OH–(Marketwire – Sep 21, 2012) – Triplefin, an industry leader in providing pharmaceutical marketing support solutions including patient reimbursement support services, patient assistance programs, traditional and alternative Rx sampling, and patient adherence solutions, announced today the launch of a new corporate-identity campaign. This campaign is designed to illuminate Triplefin’s brand support capabilities and commitment to assisting pharmaceutical manufacturing companies in successfully removing barriers to Rx brand access and adherence and connecting more patients, physicians, and payers to pharmaceutical brands.
“This is an exciting time for Triplefin and for brand managers across the pharmaceutical industry,” said Greg LaLonde, Triplefin’s Chief Executive Officer. ”Triplefin has grown very quickly both organically and through acquisition. Triplefin’s new corporate-identity campaign is a direct reflection of our rapid growth and is designed to help pharmaceutical brand managers and industry leaders understand clearly who Triplefin is and the breadth of brand support solutions that we offer to them.”
Rick Randall, Triplefin’s Chief Patient Success Officer, adds, “Like our pharmaceutical manufacturing clients, we believe the well-being of the patient and a focus on ensuring a positive, compassionate patient experience should be at the center of every transaction. We have personally witnessed our clients’ frustration in dealing with the barriers that impede patients’ access and adherence to branded medications. Triplefin provides strategic, customized solutions and state-of-the-art capabilities to identify barriers to patient access to much needed brands and provide solutions to deliver the prescribed product to the patient. Our goal is to encourage patients, health care providers, and payers to connect…and remain connected to the brand throughout the course of treatment, thereby maximizing brand growth.”
The new campaign consists of a revamped website, print and online advertising and various informational materials developed specifically to enable pharmaceutical brand managers to better understand Triplefin and the broad spectrum of Triplefin brand support solutions.
Triplefin provides an innovative and comprehensive suite of marketing and patient support solutions. Among the many innovative Triplefin Solutions are Reimbursement Support Solutions, including Instant Benefit Verification which allows the patient to quickly understand their co-pay before going to the pharmacy. Triplefin’s reimbursement solution also includes such elements as loyalty cards, vouchers, and co-pay cards designed to help reduce out-of-pocket costs and relieve the financial barriers that often impede patients’ from filling and refilling prescriptions.
Triplefin’s Patient Assistance Solutions help qualifying uninsured and underinsured patients in receiving their much needed branded medications. Triplefin’s Patient Adherence Solutions, complemented by an in-house contact center, are comprised of a variety of highly-effective refill-reminder solutions designed to keep patients on therapy. Triplefin’s Nationwide Specialty Nursing Network helps educate and assist patients with their medication.
Triplefin’s Specialty Pharmacy offers a convenient mail-order pharmacy that can handle the fulfillment and delivery of legend, refrigerated, and controlled medications. Triplefin’s order-to-cash services include multi-channel order processing; Rx product, sample, and literature fulfillment; sales and marketing support; client care; and financial management.
Through advanced technology, Triplefin is able to provide superior program data analytics and business intelligence that demonstrate solution effectiveness and assist in identifying solution modifications that will maximize brand success.
“Our suite of patient focused solutions is attractive both to individual brands within larger pharmaceutical companies as well as ‘virtual’ manufacturing clients who may have acquired or developed one or two brands and do not wish to invest in the infrastructure necessary to bring the product to market,” continues LaLonde. ”Triplefin offers brand managers the opportunity to choose those solution elements that are most conducive to growing their brand and ensuring a stellar patient experience.”
Triplefin is recognized as the premier provider of pharmaceutical marketing support solutions. For more than 30 years, Triplefin has continually helped pharmaceutical brand managers remove barriers to brand access and adherence and put prescription brands into patients’ hands…and keep them there throughout treatment. Today, more than 40 pharmaceutical manufacturing companies (including 13 of the top 20 pharmaceutical manufacturing companies), representing more than 150 brands across multiple therapeutic categories, have connected with Triplefin and experienced the success of Triplefin Solutions.
Triplefin, founded in 1981, is privately owned and headquartered in Cincinnati, Ohio. Triplefin provides strategic, customized brand support and growth solutions to leading pharmaceutical manufacturing companies. Our mission is to connect patients, providers, pharmacies, and payers to improve outcomes and to remove brand challenges with access, acquisition, and adherence.
A highly experienced team with an in-depth understanding of the pharmaceutical marketing industry is standing by to help brand managers grow their brands. For more information about Triplefin’s Solutions, please visit www.triplefin.com.